ketoprofen has been researched along with celecoxib in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 11 (47.83) | 29.6817 |
| 2010's | 9 (39.13) | 24.3611 |
| 2020's | 3 (13.04) | 2.80 |
| Authors | Studies |
|---|---|
| Aparici, M; Borràs, L; Cabré, F; Cabré, M; Carabaza, A; García, ML; González, G; Mauleón, D; Palomer, A; Pascual, J | 1 |
| Borst, P; de Haas, M; Kuil, A; Reid, G; van der Heijden, I; Wielinga, P; Wijnholds, J; Zelcer, N | 1 |
| Artursson, P; Bergström, CA; Hoogstraate, J; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Anderluh, M; Brunskole, M; Gobec, S; Lanisnik Rizner, T; Stefane, B; Stojan, J; Zorko, K | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Dalby, KN; Kaoud, TS; Radwan, MF | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Boixareu, N; Campanera, JM; Navarro, L; Pors, K; Pouplana, R; Pujol, MD; Rosell, G; Sánchez, S | 1 |
| Aramberry, L; Cesolari, JA; Godoy, A; Laudanno, OM; Piombo, G; Rocaspana, A | 1 |
| Kokki, H; Linna, TJ; Nikanne, E; Salo, J | 1 |
| Courpied, JP; Rosencher, N; Siney, H; Vastel, L | 1 |
| Béhier, JM; Calin, A; Dougados, M; Heijde, Dv; Landewé, R; Olivieri, I; Wanders, A; Zeidler, H | 1 |
| Mullangi, R; Pavan Kumar, VV; Ramani, AV; Srinivas, NR; Vinu, MC | 1 |
| Kneer, W; Lavins, BJ; Lehnhardt, K; Mazgareanu, S; Rother, M; Seidel, EJ | 1 |
| Benhamou, M; Dougados, M; Gossec, L | 1 |
| Chang, CB; Jeon, YT; Kang, YG; Kim, TK; Koh, IJ; Song, J | 1 |
| Bolten, W; Cevc, G; Conaghan, PG; Dickson, J; Rother, M | 1 |
| Kuentz, M; Niederquell, A | 1 |
| Britch, SC; Craft, RM; Hewitt, KA | 1 |
| Anaya, FJ; Henry, K; Hong, J; Innis, RB; Kim, MJ; Lee, JH; Liow, JS; Manly, LS; Pike, VW; Santamaria, JAM; Shetty, HU; Shrestha, S; Telu, S; Zanotti-Fregonara, P; Zoghbi, SS | 1 |
| Gorenflo, M; Saur, P; van den Anker, JN; van Dyk, M; Welzel, T; Ziesenitz, VC | 1 |
2 review(s) available for ketoprofen and celecoxib
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Efficacy and Safety of NSAIDs in Infants: A Comprehensive Review of the Literature of the Past 20 Years.
Topics: Adolescent; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Celecoxib; Child; Chronic Disease; Diclofenac; Flurbiprofen; Humans; Ibuprofen; Infant; Ketoprofen; Ketorolac; Meloxicam; Naproxen; Niflumic Acid; Pain | 2022 |
6 trial(s) available for ketoprofen and celecoxib
| Article | Year |
|---|---|
Celecoxib and ketoprofen for pain management during tonsillectomy: a placebo-controlled clinical trial.
Topics: Adolescent; Adult; Celecoxib; Cyclooxygenase Inhibitors; Double-Blind Method; Follow-Up Studies; Humans; Ketoprofen; Middle Aged; Pain Measurement; Pain, Postoperative; Postoperative Hemorrhage; Prospective Studies; Pyrazoles; Sulfonamides; Tonsillectomy | 2005 |
[Prevention of heterotopic ossifications in hip arthroplasty: effectiveness of selective Cox-2 inhibitors (celecoxib) versus ketoprofen].
Topics: Aged; Aged, 80 and over; Arthroplasty, Replacement, Hip; Celecoxib; Cyclooxygenase Inhibitors; Female; Humans; Infusions, Intravenous; Ketoprofen; Male; Middle Aged; Ossification, Heterotopic; Prospective Studies; Pyrazoles; Sulfonamides | 2005 |
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Disease Progression; Double-Blind Method; Drug Administration Schedule; Female; Humans; Ketoprofen; Male; Middle Aged; Pyrazoles; Radiography; Spondylitis, Ankylosing; Sulfonamides | 2005 |
Efficacy and safety of epicutaneous ketoprofen in Transfersome (IDEA-033) versus oral celecoxib and placebo in osteoarthritis of the knee: multicentre randomised controlled trial.
Topics: Administration, Cutaneous; Administration, Oral; Aged; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Disability Evaluation; Double-Blind Method; Drug Carriers; Female; Humans; Ketoprofen; Least-Squares Analysis; Male; Middle Aged; Osteoarthritis, Knee; Pain Measurement; Pyrazoles; Skin Absorption; Sulfonamides; Treatment Outcome | 2007 |
Clinical relevance of C-reactive protein in ankylosing spondylitis and evaluation of the NSAIDs/coxibs' treatment effect on C-reactive protein.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Biomarkers; C-Reactive Protein; Celecoxib; Cyclooxygenase 2 Inhibitors; Epidemiologic Methods; Female; Humans; Ketoprofen; Male; Middle Aged; Naproxen; Pyrazoles; Spondylitis, Ankylosing; Sulfonamides; Treatment Outcome | 2010 |
A multicentre, randomized, placebo- and active-controlled trial comparing the efficacy and safety of topical ketoprofen in Transfersome gel (IDEA-033) with ketoprofen-free vehicle (TDT 064) and oral celecoxib for knee pain associated with osteoarthritis.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase 2 Inhibitors; Double-Blind Method; Drug Carriers; Female; Gels; Humans; Ketoprofen; Male; Middle Aged; Osteoarthritis, Knee; Pain; Pain Measurement; Pyrazoles; Sulfonamides; Treatment Outcome; Young Adult | 2013 |
15 other study(ies) available for ketoprofen and celecoxib
| Article | Year |
|---|---|
Structure-based design of cyclooxygenase-2 selectivity into ketoprofen.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Design; Humans; Inhibitory Concentration 50; Isoenzymes; Ketoprofen; Membrane Proteins; Models, Molecular; Prostaglandin-Endoperoxide Synthases; Structure-Activity Relationship; Substrate Specificity | 2002 |
The human multidrug resistance protein MRP4 functions as a prostaglandin efflux transporter and is inhibited by nonsteroidal antiinflammatory drugs.
Topics: Adenosine Triphosphate; Alprostadil; Animals; Anti-Inflammatory Agents, Non-Steroidal; Biological Transport; Cell Line; Cell Membrane; Diffusion; Dinoprost; Dinoprostone; Dose-Response Relationship, Drug; Humans; Insecta; Multidrug Resistance-Associated Proteins; Prostaglandins; Prostaglandins A; Prostaglandins F; Ribosomal Proteins; RNA Interference; RNA, Small Interfering; Thromboxane B2; Time Factors | 2003 |
Prediction and identification of drug interactions with the human ATP-binding cassette transporter multidrug-resistance associated protein 2 (MRP2; ABCC2).
Topics: Administration, Oral; Animals; Antineoplastic Agents; Antipsychotic Agents; Antiviral Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Biological Transport; Cell Line; Computer Simulation; Cytochrome P-450 Enzyme System; Drug-Related Side Effects and Adverse Reactions; Estradiol; Humans; Insecta; Liver; Models, Molecular; Multidrug Resistance-Associated Protein 2; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Pharmaceutical Preparations; Pharmacology; Structure-Activity Relationship | 2008 |
Towards the first inhibitors of trihydroxynaphthalene reductase from Curvularia lunata: synthesis of artificial substrate, homology modelling and initial screening.
Topics: Amino Acid Sequence; Ascomycota; Benzopyrans; Enzyme Inhibitors; Fungal Proteins; Melanins; Models, Molecular; Molecular Sequence Data; Oxidoreductases Acting on CH-CH Group Donors; Recombinant Proteins; Structural Homology, Protein; Substrate Specificity | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Propyphenazone-based analogues as prodrugs and selective cyclooxygenase-2 inhibitors.
Topics: | 2014 |
Synthesis and biological properties of aryl methyl sulfones.
Topics: Acetic Acid; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Carrageenan; Dimethyl Sulfoxide; Dose-Response Relationship, Drug; Edema; Humans; Male; Mice; Models, Molecular; Molecular Structure; Rats; Rats, Sprague-Dawley; Stomach Ulcer; Structure-Activity Relationship; Sulfones; Thermodynamics | 2018 |
[Dexketoprofene, selective cox-1 inhibitor nsaids, without gastrointestinal injury in rats].
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Cyclooxygenase Inhibitors; Drug Evaluation, Preclinical; Gastric Mucosa; Humans; Intestinal Mucosa; Ketoprofen; Ketorolac; Pyrazoles; Rats; Rats, Wistar; Sulfonamides; Tromethamine | 2002 |
Simultaneous quantitation of etoricoxib, salicylic acid, valdecoxib, ketoprofen, nimesulide and celecoxib in plasma by high-performance liquid chromatography with UV detection.
Topics: Animals; Celecoxib; Chromatography, High Pressure Liquid; Etoricoxib; Humans; Isoxazoles; Ketoprofen; Male; Pyrazoles; Pyridines; Rats; Rats, Wistar; Reproducibility of Results; Salicylic Acid; Spectrophotometry, Ultraviolet; Sulfonamides; Sulfones | 2006 |
Use of reduced-dose periarticular injection for pain management in simultaneous bilateral total knee arthroplasty.
Topics: Aged; Amides; Analgesics, Opioid; Anesthesia, Spinal; Anesthetics, Local; Anti-Bacterial Agents; Arthroplasty, Replacement, Knee; Bupivacaine; Case-Control Studies; Cefuroxime; Celecoxib; Cyclooxygenase 2 Inhibitors; Drug Therapy, Combination; Epinephrine; Female; Fentanyl; Humans; Incidence; Injections, Intra-Articular; Ketoprofen; Male; Morphine; Oxycodone; Pain Management; Pain Measurement; Postoperative Complications; Prospective Studies; Pyrazoles; Ropivacaine; Statistics, Nonparametric; Sulfonamides; Treatment Outcome | 2012 |
Biorelevant dissolution of poorly soluble weak acids studied by UV imaging reveals ranges of fractal-like kinetics.
Topics: Celecoxib; Chemistry, Pharmaceutical; Hydrogen-Ion Concentration; Ketoprofen; Kinetics; Microscopy, Electron, Scanning; Naproxen; Powder Diffraction; Pyrazoles; Solubility; Spectrum Analysis, Raman; Sulfathiazole; Sulfathiazoles; Sulfonamides; X-Ray Diffraction | 2014 |
Antinociception produced by nonsteroidal anti-inflammatory drugs in female vs male rats.
Topics: Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Celecoxib; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Freund's Adjuvant; Hyperalgesia; Ibuprofen; Inflammation; Ketoprofen; Male; Pain; Rats; Rats, Sprague-Dawley; Sex Factors | 2021 |
Whole-Body PET Imaging in Humans Shows That
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Celecoxib; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Humans; Ketoprofen; Positron-Emission Tomography | 2023 |